Activity Provided By:

ACHL

Highlights from the 2018 C3 Symposium on the long-term effects of emerging cholesterol therapies in statin resistant patients and strategies for their management.

Overview / Abstract:	As presented at the 2018 C3 annual meeting, clinicians can learn about strategies to effectively apply new cholesterol therapies in diverse patient populations, clinical implications of the latest outcomes data from the FOURIER, ODYSSEY and SPIRE Trials, and access, cost, and non-adherence challenges of PCSK9 inhibitor therapy.
Expiration	Jul 26, 2019
Discipline(s)	Physician CME
Format	Webinar / Webcast / Video
Credits / Hours	1.25
Accreditation	ACHL designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Is This Activity Certified for "Live" Credit?	YES
Presenters / Authors / Faculty	Chairperson: Peter Libby, MD Mallinckrodt Professor of Medicine, Harvard Medical School Cardiovascular Specialist, Brigham and Women’s Hospital Boston, Massachusetts Co-Chairperson: Raj Dave, MD, FACC, FSCAI Chief Medical Executive, Holy Spirit Cardiovascular Institute Chairman, Department of Cardiology Director, Cardiac Catheterization Laboratories The Ortenzio Heart Center at Holy Spirit Hospital Camp Hill, Pennsylvania Faculty: Alan Brown, MD Director, Division of Cardiology Advocate Heart Institute at Lutheran General Hospital President, National Lipid Society Park Ridge, Illinois Nihar Desai, MD, MPH Assistant Professor of Medicine Yale School of Medicine West Haven, Connecticut Dinesh Kalra, MD, FACC Assistant Professor Rush University Medical Center Chicago, Illinois
Activity Specialities / Related Topics	Cardiology / Cardiovascular
Sponsors / Supporters / Grant Providers	Sponsored by the Academy for Continued Healthcare Learning and Interventional Academy Supported by an educational grant from Sanofi-Regeneron Alliance
Keywords / Search Terms	ACHL PCSK9 inhibitors, dyslipidemia, hyperlipidemia, FOURIER, ODYSSEY, LDL-C, ACS, CME, CE, Continuing Medical Education, Online Learning, Cardiology, Interventional Cardiology, Cardiovascular Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map